Source: Annual Congress 2009 - Pathogenesis of lung cancer
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. E. Carpagnano, G. Ciliberti, G. P. Palladino, L. Iassaldano, V. Defilippis, S. Notarangelo, R. Decembrino, M. P. Foschino Barbaro, V. Turchiarelli, E. Costantino (Foggia, Italy). Cigarette smoke and increased COX-2 and survivin levels in exhaled breath condensate of lung cancer patients: how hot is the link?. Eur Respir J 2009; 34: Suppl. 53, 4202

Member's Comments

No comment yet.

Related content which might interest you: Pretreatment levels of TNF-α in serum and exhaled breath condensate in patients with lung cancer Source: Annual Congress 2007 - Biology of thoracic malignancies Year: 2007 HPV in exhaled breath condensate of lung cancer patients Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011 Periostin in exhaled breath condensate as a biomarker of different severe asthma phenotypes. Source: International Congress 2017 – Systemic and airway biomarkers Year: 2017 Exhaled biomarkers in lung cancer Source: Eur Respir J 2009; 34: 261-275 Year: 2009 The impact of acute smoke exposure on selected biomarkers in exhaled breath condensate in COPD patients and healthy smokers Source: International Congress 2016 – Molecular pathways of smoking-induced diseases Year: 2016 Pretreatment levels of VEGF and 8-isoprostane in exhaled breath condensate (EBC) and serum of lung cancer patients Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology Year: 2008 8-isoprostane in exhaled breath condensate in healthy and asthmatic children, and its relationship with tobacco smoke exposure Source: Annual Congress 2011 - Inflammation and genes in childhood asthma Year: 2011 Protein markers in the exhaled breath condensate of lung carcinoma patients Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases Year: 2012 Increased IL-6 in the breath condensate of smokers Source: Eur Respir J 2002; 20: Suppl. 38, 281s Year: 2002 Nitrite concentration in exhaled breath condensate correlates with markers of lung overdistension in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 317s Year: 2004 Non-invasive lung cancer diagnosis by detection of GATA6 and NKX2-1 isoforms in exhaled breath condensate Source: International Congress 2017 – Clinical research in lung cancer: new valuable results on lung cancer detection, prognostic biomarkers, and tyrosine kinase inhibitors Year: 2017 Detection of p53 mutation in exhaled breath condensate from patients with nonsmall cell lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 14s Year: 2002 The effect of environmental tobacco smoke on the quantity of oxidant/antioksidant markers in exhaled breathe condensate Source: Annual Congress 2010 - Smoking related diseases, damages due to environmental tobacco smoke and smoking control strategies Year: 2010 Relationships between the concentrations of NO, IL1β, TNF-α, IL-6 in exhaled breath condensate (EBC) and lung function in patient with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 61s Year: 2005 Increased 8-isoprostane in the exhaled breath condensate of down patients Source: Eur Respir J 2004; 24: Suppl. 48, 556s Year: 2004 N-acetylcysteine reduces 8-isoprostane levels in exhaled breath condensate and serum of COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 13s Year: 2005 Decreased levels of bis-S-bimane in exhaled breath condensate of COPD Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015 Exhaled breath condensate total NOx in chronic lung disease in response to changes in ambient air pollution Source: Annual Congress 2007 - What's new in air pollution from experiments to epidemiology Year: 2007 Increased inflammatory markers in the exhaled breath condensate of cigarette smokers Source: Eur Respir J 2003; 21: 589-593 Year: 2003 Structures of an exhaled breath condensate in lung diseases Source: Eur Respir J 2005; 26: Suppl. 49, 525s Year: 2005